InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong
· Delayed Price · Currency is HKD
62.85
+3.40 (5.72%)
Last updated: Mar 10, 2026, 11:59 AM HKT
HKG:3696 Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -44.34 | -17.1 | -211.64 | -221.83 |
| Depreciation & Amortization | 5.49 | 6.05 | 4.48 | 1.78 |
| Loss (Gain) From Sale of Assets | 0 | - | 0.01 | 2.19 |
| Loss (Gain) From Sale of Investments | -1.91 | -0.56 | -0.45 | 1.04 |
| Stock-Based Compensation | 3.13 | 3.26 | 10.79 | 12.92 |
| Provision & Write-off of Bad Debts | 0.04 | -0.01 | -0.16 | 0.23 |
| Other Operating Activities | -15.03 | -15.91 | 122.23 | 138.53 |
| Change in Accounts Receivable | 1.45 | 2.86 | 2.11 | -5.95 |
| Change in Accounts Payable | -8 | 0.29 | 9.14 | 12.69 |
| Change in Unearned Revenue | -1.38 | -35.56 | 37.43 | 5.03 |
| Change in Other Net Operating Assets | -2.98 | -0.73 | -3.52 | 5.84 |
| Operating Cash Flow | -61.87 | -57.4 | -29.58 | -47.52 |
| Capital Expenditures | -0.87 | -0.84 | -2.56 | -10.98 |
| Sale of Property, Plant & Equipment | 0.01 | - | 0.01 | - |
| Divestitures | - | - | - | -2.22 |
| Sale (Purchase) of Intangibles | -0.06 | -0.08 | -0.41 | -0.24 |
| Other Investing Activities | 6.42 | 8.35 | 3.66 | -0.15 |
| Investing Cash Flow | 18.24 | 7.42 | 0.69 | -13.58 |
| Long-Term Debt Repaid | - | -1.56 | -1.4 | -0.97 |
| Net Debt Issued (Repaid) | -1.73 | -1.56 | -1.4 | -0.97 |
| Issuance of Common Stock | 0.42 | 0.41 | 0.01 | 0.21 |
| Other Financing Activities | -0.61 | -0.38 | -0.79 | -1.83 |
| Financing Cash Flow | 119.73 | -1.54 | -2.18 | 107.15 |
| Foreign Exchange Rate Adjustments | 0.24 | 0.28 | 0.37 | 0.29 |
| Net Cash Flow | 76.35 | -51.24 | -30.7 | 46.34 |
| Free Cash Flow | -62.74 | -58.25 | -32.14 | -58.5 |
| Free Cash Flow Margin | -117.05% | -67.86% | -62.79% | -194.03% |
| Free Cash Flow Per Share | -0.82 | -0.81 | -0.48 | -0.87 |
| Cash Interest Paid | 0.15 | 0.09 | 0.09 | 0.1 |
| Levered Free Cash Flow | - | -56.4 | 128.96 | - |
| Unlevered Free Cash Flow | - | -56.34 | 129.02 | - |
| Change in Working Capital | -10.9 | -33.14 | 45.16 | 17.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.